MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
457.16%
Quick Ratio
457.16%
Cash Ratio
116.22%
Debt to Asset Ratio
57.55%
Unit: Thousand (K) dollars
Assets Breakdown
Operating lease right-of-use ass...
Marketable securities
Restricted cash and cash equival...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Operating lease liabilities, non...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
84,535
143,864
167,202
111,065
Marketable securities
217,628
229,592
255,418
350,797
Accounts receivable, net
13,013
19,815
24,026
21,430
Accounts receivable - related parties
0
454
229
929
Prepaid expenses and other current assets (includes 4,444 and zero from related parties)
17,359
16,230
24,963
21,861
Total current assets
332,535
409,955
471,838
506,082
Restricted cash and cash equivalents, non-current
84,565
-
-
-
Property, plant and equipment, net
157,185
163,020
167,783
176,579
Operating lease right-of-use assets
347,661
353,804
360,918
368,213
Investments
14,775
14,703
15,066
30,175
Equity method investments
7,615
-
-
-
Intangible assets, net
44,387
48,860
56,924
61,522
Other non-current assets
1,323
39,522
47,167
46,594
Assets held for sale
0
3,211
-
-
Total assets
990,046
1,033,075
1,119,696
1,189,165
Accounts payable
9,575
16,309
10,566
10,704
Deferred revenue (includes 98 and 98 from related parties)
13,214
14,910
18,946
25,236
Accrued expenses and other current liabilities (includes 2,513 and zero from related parties)
49,951
48,376
66,458
79,341
Total current liabilities
72,740
79,595
95,970
115,281
Deferred revenue, net of current portion (includes 64,810 and 64,787 from related parties)
76,537
77,895
75,182
74,072
Operating lease liabilities, non-current
404,113
410,700
417,078
422,870
Other non-current liabilities
16,372
21,732
22,876
17,159
Total liabilities
569,762
589,922
611,106
629,382
Common stock, 0.0001 par value (note 8)
6
6
6
6
Additional paid-in capital
6,698,945
6,674,860
6,657,053
6,627,350
Accumulated deficit
-6,279,617
-6,232,907
-6,150,320
-6,069,569
Accumulated other comprehensive income
950
1,194
1,851
1,996
Total stockholders equity
420,284
443,153
508,590
559,783
Total liabilities and stockholders equity
990,046
1,033,075
1,119,696
1,189,165
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$217,628K
Cash and cash
equivalents
$84,535K
Prepaid expenses and
other current assets...
$17,359K
Accounts receivable, net
$13,013K
Operating lease
right-of-use assets
$347,661K
Total current assets
$332,535K
Property, plant and
equipment, net
$157,185K
Restricted cash and cash
equivalents, non-current
$84,565K
Intangible assets, net
$44,387K
Investments
$14,775K
Equity method
investments
$7,615K
Other non-current
assets
$1,323K
Total assets
$990,046K
Total liabilities and
stockholders equity
$990,046K
Total liabilities
$569,762K
Total stockholders
equity
$420,284K
Accumulated deficit
-$6,279,617K
Operating lease
liabilities, non-current
$404,113K
Deferred revenue, net of
current portion...
$76,537K
Total current
liabilities
$72,740K
Other non-current
liabilities
$16,372K
Additional paid-in capital
$6,698,945K
Accumulated other
comprehensive income
$950K
Common stock, 0.0001
par value (note 8)
$6K
Accrued expenses and
other current...
$49,951K
Deferred revenue
(includes 98 and 98 from...
$13,214K
Accounts payable
$9,575K
Buy us a coffee
Ginkgo Bioworks Holdings, Inc. (DNABW)
Ginkgo Bioworks Holdings, Inc. (DNABW)